World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 17 October 2016
Main ID:  ISRCTN13078441
Date of registration: 18/04/2016
Prospective Registration: No
Primary sponsor: Maasstad Hospital Rotterdam (Maasstadziekenhuis Rotterdam)
Public title: PowerCoaching: A multiple domain CBT coaching program for adolescents with attention deficit hyperactivity disorder
Scientific title: An RCT pilot of treatment as usual compared to PowerCoaching: An multiple domain CBT coaching program for adolescents between 12 and 18 years old with Attention Deficit Hyperactivity Disorder
Date of first enrolment: 12/02/2015
Target sample size: 30
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN13078441
Study type:  Interventional
Study design:  18-week immediate versus delayed intervention randomised controlled trial (Treatment)  
Phase: 
Countries of recruitment
Netherlands
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Athanasios    Maras
Address:  Yulius Academie Dennenhout 1 2994GC Barendrecht Netherlands
Telephone: +31 88 403 6950
Email: a.maras@yulius.nl
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Aged 12 to 18 years
2. An official Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV ADHD diagnosis (all subtypes). The diagnosis must have been previously set by a child and adoelscent psychiatrist, Healthcare psychologist, clinical psychologist or paediatrician specialized in social paediatrics. Adolescents with common diagnosed comorbid disorders (i.e., dyslexia, oppositional defiant disorder) can participate in the study as long as ADHD is the main disorder.
3. Stable ADHD treatment, both pharmacological and psychological
4. Minimum total intelligence quotiënt (TIQ) score must be greater than or equal to 85
5. Fluent in Dutch
6. Provision of written informed consent

Exclusion criteria: 1. Addiction to drugs or alcohol
2. Severe psychotic disorder
3. Another acute Axis-I disorder


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Attention deficit hyperacitivty disorder (ADHD) and problems in daily functioning
Mental and Behavioural Disorders
Attention deficit hyperacitivty disorder (ADHD)
Intervention(s)
Adolescents are randomized to one of two groups:

Immediate treatment group: Participants receive the PowerCoaching for a total of 18 weeks. Sessions are given once a week at the participant's home, lasting for 45 to 60 minutes, and involve the discussion of different themes (i.e. psycho-education, planning and organisation, school and study, self-image, emotion regulation, relations, risk and control and lifestyle). During the sessions, participants will learn new strategies to cope with ADHD related problems.

Delayed treatment group: For the 18 week duration of the study, participants continue as usual. Following collection of the final outcomes, the treatment is made available from week 19 to week 37.

Participants in both groups complete outcome measurements at baseline and 18 weeks.
Primary Outcome(s)
Quality of life is measured using “Weiss Functional Impairment Rating Scale (WFRIS) excluding the subscale ‘work’ at baseline and 18 weeks.
Secondary Outcome(s)
1. Self-efficiency measured using a self-constructed questionnaire at baseline and 18 weeks
2. selfregulating behavior measured using the Behavior Rating Iventory Executive Functions's subscales emotion regulation, planning and organizing, and organization of materials at baseline and 18 weeks
3. Psychosocial problems measured using the Strengths and Difficulties Questionnaire at baseline and 18 weeks
Secondary ID(s)
N/A
Source(s) of Monetary Support
Yulius
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history